Hospital · Private company
H. Lee Moffitt Cancer Center and Research Institute
Track this companyFree. Adds H. Lee Moffitt Cancer Center and Research Institute to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Intermittent Fasting for PancreatitisNA · NOT_YET_RECRUITING · started Sep 1, 2027ClinicalTrials.gov NCT04760847 · fetched Nov 12, 2026
- Modifying Diet to Improve Gut MicrobiomeNA · NOT_YET_RECRUITING · started Jul 1, 2027ClinicalTrials.gov NCT03924778 · fetched Nov 12, 2026
- Adjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA MonitoringPHASE2 · RECRUITING · started Oct 21, 2026ClinicalTrials.gov NCT07930182 · fetched Nov 12, 2026
- Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesPHASE1 · RECRUITING · started Feb 5, 2026ClinicalTrials.gov NCT07194044 · fetched Nov 12, 2026
- Digoxin Medulloblastoma StudyPHASE2 · RECRUITING · started Jan 15, 2026ClinicalTrials.gov NCT06701812 · fetched Nov 12, 2026
- Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology AgentsPHASE1 · RECRUITING · started Jun 24, 2025ClinicalTrials.gov NCT06963346 · fetched Nov 12, 2026
- Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLCPHASE2 · RECRUITING · started Jun 13, 2025ClinicalTrials.gov NCT06745882 · fetched Nov 12, 2026
- Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid TumorsPHASE1 · RECRUITING · started Jun 2, 2025ClinicalTrials.gov NCT06047977 · fetched Nov 12, 2026
- Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCLPHASE2 · RECRUITING · started Aug 23, 2024ClinicalTrials.gov NCT06553872 · fetched Nov 12, 2026
- Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)RECRUITING · started May 1, 2024ClinicalTrials.gov NCT06423950 · fetched Nov 12, 2026
- Rituximab and Zanubrutinib in Patients With Indolent B-cell LymphomasPHASE2 · RECRUITING · started Apr 19, 2024ClinicalTrials.gov NCT06350318 · fetched Nov 12, 2026
- High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)NA · ACTIVE_NOT_RECRUITING · started Apr 4, 2024ClinicalTrials.gov NCT06337552 · fetched Nov 12, 2026
- Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)RECRUITING · started Jan 22, 2024ClinicalTrials.gov NCT06305676 · fetched Nov 12, 2026
- Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)PHASE2 · RECRUITING · started Dec 26, 2023ClinicalTrials.gov NCT06144606 · fetched Nov 12, 2026
- Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority PopulationsACTIVE_NOT_RECRUITING · started Feb 22, 2023ClinicalTrials.gov NCT05687188 · fetched Nov 12, 2026
- Genomically Guided Radiation Therapy in the Management of Triple Negative Breast CancerPHASE2 · RECRUITING · started Jan 25, 2023ClinicalTrials.gov NCT05528133 · fetched Nov 12, 2026
- HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)NA · ACTIVE_NOT_RECRUITING · started Jan 9, 2023ClinicalTrials.gov NCT05677360 · fetched Nov 12, 2026
- Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian CancerPHASE1 · RECRUITING · started Apr 28, 2022ClinicalTrials.gov NCT05316129 · fetched Nov 12, 2026
- Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCTPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 21, 2022ClinicalTrials.gov NCT05015426 · fetched Nov 12, 2026
- Automated Video-Assisted Smoking Treatment for People Living With HIVNA · ACTIVE_NOT_RECRUITING · started Dec 15, 2021ClinicalTrials.gov NCT05014282 · fetched Nov 12, 2026
- SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain MetastasesPHASE1_PHASE2 · RECRUITING · started Nov 30, 2021ClinicalTrials.gov NCT04923542 · fetched Nov 12, 2026
- Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in MelanomaEARLY_PHASE1 · RECRUITING · started May 24, 2021ClinicalTrials.gov NCT04741997 · fetched Nov 12, 2026
- Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T TherapyPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 18, 2021ClinicalTrials.gov NCT04745559 · fetched Nov 12, 2026
- Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the PancreasACTIVE_NOT_RECRUITING · started Feb 18, 2020ClinicalTrials.gov NCT04275557 · fetched Nov 12, 2026
- Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Mar 22, 2016ClinicalTrials.gov NCT02638090 · fetched Nov 12, 2026